Agenus AGEN
NASDAQ AGEN
$8.24 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Agenus (AGEN) Other Non-Current Assets (2010 - 2026)

Agenus (AGEN) posted quarterly Other Non-Current Assets of $3.0 million for Q1 2026, down 46.23% year-over-year from $5.6 million in Q1 2025, and down 8.89% quarter-over-quarter from $3.3 million in Q4 2025.

Analysis

Agenus (AGEN) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Agenus' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 46.23% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 46.23% YoY), while the FY2025 annual figure was $3.3 million, down 43.32% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $3.0 million, down from $3.3 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $12.5 million in Q1 2022, with the low at $3.0 million in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $6.6 million (2024), against an average of $6.7 million.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 199.12% in 2022, then slumped 64.74% in 2023.
  • Agenus' Other Non-Current Assets stood at $4.5 million in 2022, then surged by 109.66% to $9.3 million in 2023, then tumbled by 37.51% to $5.8 million in 2024, then slumped by 43.32% to $3.3 million in 2025, then declined by 8.89% to $3.0 million in 2026.
  • Business Quant data shows AGEN's Other Non-Current Assets at $3.0 million in Q1 2026, $3.3 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Agenus 342.07 Mn 342.07 Mn 34.52 Mn 3.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.86 Mn
Mar 31, 2026 3.01 Mn
Dec 31, 2025 3.31 Mn
Sep 30, 2025 3.19 Mn
Jun 30, 2025 5.44 Mn
Mar 31, 2025 5.60 Mn
Dec 31, 2024 5.83 Mn
Sep 30, 2024 6.60 Mn
Jun 30, 2024 6.99 Mn
Mar 31, 2024 7.61 Mn
Dec 31, 2023 9.34 Mn
Sep 30, 2023 11.06 Mn
Jun 30, 2023 9.26 Mn
Mar 31, 2023 4.42 Mn
Dec 31, 2022 4.45 Mn
Sep 30, 2022 7.92 Mn
Jun 30, 2022 7.92 Mn
Mar 31, 2022 12.53 Mn
Dec 31, 2021 9.54 Mn
Sep 30, 2021 14.19 Mn